LRP6 and cancer: As ECM-CAFs originate from resident liver fibroblasts, it is interesting to note that in hepatocytes, Wnt/β-catenin signaling can synergize with insulin signaling through IGF1R, LRP5, and LRP6 34, which were concomitantly enriched in ECM-CAF-cancer cell LR interactions.